DPP4 and Miyoshi myopathy: Similarly, a DPP4-targeting humanized mAb (huCD26mAb) exhibited cytotoxic activity against MM cells and also inhibited their adhesion to bone marrow stromal cells, a key mechanism that supports MM cell growth and survival in the bone marrow niche [104].